Fri. 1 Mar 2024, 6:02am ET
Benzinga
Earnings, News
Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 39.13 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $616.98 million which missed the analyst consensus estimate of $634.23 million by 2.72 percent. This is a 1.18 percent increase over sales of $609.76 million the same period last year.